These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 18385524)
1. Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Li D; Yue Y; Duan D Am J Pathol; 2008 May; 172(5):1332-41. PubMed ID: 18385524 [TBL] [Abstract][Full Text] [Related]
2. Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle. Wieneke S; Heimann P; Leibovitz S; Nudel U; Jockusch H J Appl Physiol (1985); 2003 Nov; 95(5):1861-6. PubMed ID: 14555666 [TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
4. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Li D; Long C; Yue Y; Duan D Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360 [TBL] [Abstract][Full Text] [Related]
5. A marginal level of dystrophin partially ameliorates hindlimb muscle passive mechanical properties in dystrophin-null mice. Hakim CH; Duan D Muscle Nerve; 2012 Dec; 46(6):948-50. PubMed ID: 23225385 [TBL] [Abstract][Full Text] [Related]
6. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice. Yue Y; Liu M; Duan D Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874 [TBL] [Abstract][Full Text] [Related]
7. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734 [TBL] [Abstract][Full Text] [Related]
8. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512 [TBL] [Abstract][Full Text] [Related]
13. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points. Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817 [TBL] [Abstract][Full Text] [Related]
14. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. Claflin DR; Brooks SV Am J Physiol Cell Physiol; 2008 Feb; 294(2):C651-8. PubMed ID: 18171725 [TBL] [Abstract][Full Text] [Related]
16. iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice. Li D; Shin JH; Duan D PLoS One; 2011; 6(6):e21618. PubMed ID: 21738735 [TBL] [Abstract][Full Text] [Related]